1. P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation
- Author
-
Zhonghua Wang, Hidemasa Goto, Masaki Inagaki, Kousuke Kasahara, Tohru Kiyono, Ping Li, Yasushi Yatabe, and Makoto Matsuyama
- Subjects
Cytoplasm ,animal structures ,MAP Kinase Signaling System ,genetic processes ,Cell Cycle Proteins ,Ataxia Telangiectasia Mutated Proteins ,Protein Serine-Threonine Kinases ,Biology ,Ribosomal Protein S6 Kinases, 90-kDa ,environment and public health ,Genomic Instability ,Ribosomal s6 kinase ,Cell Line, Tumor ,Humans ,CHEK1 ,Phosphorylation ,RNA, Small Interfering ,Protein kinase A ,Molecular Biology ,Cell Proliferation ,Cell Nucleus ,Cell growth ,Kinase ,Cell Cycle ,Autophosphorylation ,Articles ,Cell Biology ,Cell cycle ,Molecular biology ,Signaling ,Cell biology ,Protein Transport ,enzymes and coenzymes (carbohydrates) ,Checkpoint Kinase 1 ,biology.protein ,RNA Interference ,Mitogen-Activated Protein Kinases ,biological phenomena, cell phenomena, and immunity ,Protein Kinases ,Proto-Oncogene Proteins c-akt ,HeLa Cells - Abstract
P90 RSK, but not Akt/PKB, facilitates nuclear retention of Chk1 through Chk1–Ser-280 phosphorylation in response to serum stimulation. Chk1–Ser-280 phosphorylation is also elevated in a p90 RSK–dependent manner after UV irradiation and accelerates the Chk1 activation process (Ser-345 and Ser-296 phosphorylation on Chk1) after UV irradiation., The ataxia telangiectasia mutated- and rad3-related kinase (ATR)/Chk1 pathway is a sentinel of cell cycle progression. On the other hand, the Ras/mitogen-activated protein kinase/90-kDa ribosomal S6 kinase (p90 RSK) pathway is a central node in cell signaling downstream of growth factors. These pathways are closely correlated in cell proliferation, but their interaction is largely unknown. Here we show that Chk1 is phosphorylated predominantly at Ser-280 and translocated from cytoplasm to nucleus in response to serum stimulation. Nonphosphorylated Chk1–Ser-280 mutation attenuates nuclear Chk1 accumulation, whereas the phosphomimic mutation has a reverse effect on the localization. Treatment with p90 RSK inhibitor impairs Chk1 phosphorylation at Ser-280 and accumulation at the nucleus after serum stimulation, whereas these two phenomena are induced by the expression of the constitutively active mutant of p90 RSK in serum-starved cells. In vitro analyses indicate that p90 RSK stoichiometrically phosphorylates Ser-280 on Chk1. Together with Chk1 phosphorylation at Ser-345 by ATR and its autophosphorylation at Ser-296, which are critical for checkpoint signaling, Chk1–Ser-280 phosphorylation is elevated in a p90 RSK–dependent manner after UV irradiation. In addition, Chk1 phosphorylation at Ser-345 and Ser-296 after UV irradiation is also attenuated by the treatment with p90 RSK inhibitor or by Ser-280 mutation to Ala. These results suggest that p90 RSK facilitates nuclear Chk1 accumulation through Chk1–Ser-280 phosphorylation and that this pathway plays an important role in the preparation for monitoring genetic stability during cell proliferation.
- Published
- 2012
- Full Text
- View/download PDF